Predict. Personalize. Cure.
Utilising the latest organoid technology, we test personalised response of each patient towards different cancer therapies. Currently, we focus specifically on gastrointestinal cancer, including colorectal, gastric, and liver cancers, three of the top five common cancers in HK and China.